NCT00861783 2017-06-23Safety of ON 01910.Na and Irinotecan or ON 01910.Na and Oxaliplatin in Patients With HepatomaTraws Pharma, Inc.Phase 1 Completed16 enrolled
NCT00635323 2008-04-07Safety And Efficacy Of Irinotecan Plus Capecitabine As First-Line Treatment In Asian Subjects With Hepatocellular CarcinomaPfizerPhase 2 Completed73 enrolled